Ignite Creation Date:
2024-05-06 @ 3:15 PM
Last Modification Date:
2025-12-16 @ 11:45 PM
Study NCT ID:
NCT04576117
Status:
None
Last Update Posted:
2025-11-19 00:00:00
First Post:
2020-10-03 00:00:00
Brief Title:
A Study to Compare Treatment With the Drug Selumetinib Alone Versus Selumetinib and Vinblastine in Patients With Recurrent or Progressive Low-Grade Glioma
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute (NCI)
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Refractory WHO Grade 1 Glioma |
| Recurrent Low Grade Astrocytoma |
| Recurrent WHO Grade 2 Glioma |
| Refractory Low Grade Astrocytoma |
| Refractory Low Grade Glioma |
Keywords: